REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Choosing a treatment to manage the symptoms of your anemia
is a joint decision between you, your caregiver(s), and your healthcare team. If you have very low- to intermediate-risk myelodysplastic syndromes (MDS)
and anemia, REBLOZYL may be a treatment option for you.
When thinking about prescribing REBLOZYL, your healthcare team will also consider factors, such as:
Your current treatments
How often you have red blood cell (RBC) transfusions (sometimes called a transfusion burden)
If you have any other health conditions, such as high blood pressure or have had previous blood clots
Considering these factors will help your doctor determine if REBLOZYL is right for you.
Every medicine comes with certain benefits and important safety considerations. These might include:
Having open conversations with your healthcare team is crucial to managing your treatment. Doing this from the start will set a strong foundation that will continue over time.
Ask questions
Come to appointments prepared with any information you’ve been keeping track of. This information can include recent blood
transfusions, recent hemoglobin (Hgb)
levels, and any new or changing symptoms
Talk openly about how treatment is going
Stay connected to the
support you need
Your REBLOZYL Connection is an educational program designed to help you understand your treatment with REBLOZYL, and provide resources that allow you to be more active role with your care.